Siemens plans to transfer its stake in a nuclear magnetic resonance equipment manufacturer valued at 15 billion euros to investors
西門子股份公司（Siemens Healthineers AG）30% 的股權移交給自己的股東，使其能夠減少對醫療技術業務的持股，並將重點放在軟件業務上。此舉將使西門子在該前子公司中保留 37% 的股權，該公司目標是在中期內將該股權減持至一項金融資產。這項直接分拆尚需監管機構和股東批准，西門子將於明年提供更多細節。
Source: 華爾街見聞 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments